Steven Sarner
Psychiatry · Newton, NJNPI 1205807930
Payments from drug & device makers
Across 238 payments — averaging $12.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$878
- Otsuka America Pharmaceutical, Inc.$632
- Sunovion Pharmaceuticals Inc.$614
- Lundbeck LLC$181
- Johnson & Johnson$173
- Neurocrine Biosciences, Inc.$111
- plus $303 from 6 others
What the payments were for
- Food & beverage$2,892100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $878 |
| Otsuka America Pharmaceutical, Inc. | 22 | $632 |
| Sunovion Pharmaceuticals Inc. | 60 | $614 |
| Lundbeck LLC | 14 | $181 |
| Johnson & Johnson | 14 | $173 |
| Neurocrine Biosciences, Inc. | 8 | $111 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $93 |
| Alkermes, Inc. | 6 | $84 |
| Almatica Pharma LLC | 3 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,892 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 42 | $113,559 |
| Austedo XrDeutetrabenazine | 27 | $100,451 |
| Invega SustennaPaliperidone Palmitate | 24 | $72,623 |
| RexultiBrexpiprazole | 40 | $70,265 |
| VraylarCariprazine Hcl | 28 | $65,694 |
| LatudaLurasidone Hcl | 15 | $26,227 |
| SeroquelQuetiapine Fumarate | 15 | $25,435 |
| Aripiprazole | 229 | $21,723 |
| TrintellixVortioxetine Hydrobromide | 36 | $19,115 |
| Lurasidone Hcl | 90 | $13,222 |
| Chlorpromazine Hcl | 31 | $10,740 |
| Clozapine | 118 | $8,124 |
| LamictalLamotrigine | 12 | $7,594 |
| Paliperidone ErPaliperidone | 20 | $7,566 |
| TrileptalOxcarbazepine | 12 | $6,757 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $632 | $183,82482 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $40 | $100,45127 claims |
| Johnson & JohnsonInvega Sustenna | $173 | $72,62324 claims |
| AbbVieVraylar | $878 | $65,69428 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $614 | $26,22715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Newton
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.